The largest database of trusted experimental protocols

78 protocols using pt 2501

1

Reaggregation of HUVEC, MSC, and sBC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVEC) (C2519A; Lonza) and human mesenchymal stem cells (PT-2501; Lonza PT-2501) were grown as per the manufacture’s instruction. For reaggregation experiments a total of 1,000 sBC were sorted and reaggregated with 100 human mesenchymal stem cells and 400 HUVEC for 2 days in round bottom plates in a 50:50 mixture of maturation and HUVEC culture media as previously described (35 (link)).
+ Open protocol
+ Expand
2

Murine CD4+ T Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cell suspension of splenocytes from 6- to 8-week-old male mice was prepared, and the
erythrocytes were lysed with ACK (R7757, Sigma-Aldrich). The CD4+ T cells were
purified by using a CD4+ T-cell Isolation kit (130-104-454, Miltenyi Biotech)
according to the manufacturer’s instructions. The purity of the CD4+ T cells
was confirmed using a CD4 antibody (FITC-conjugated anti-mouse CD4, 553729, BD
Biosciences) and was greater than 96%. For the T-cell proliferation assay, CD4+T cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE; 565082,
BD Biosciences). Freshly purified T cells were labeled with 1.2 μM CFSE for 10 min at 37°C
and were then washed three times in complete medium. CFSE-labeled CD4+ T cells
were co-cultured with adult SCs, ESC-derived SLCs, human bone marrow-derived mesenchymal
stem cells (BM-MSC, PT-2501, Lonza, Allendale, NJ), or isolated spleen cells at a 5:1
ratio. The cells were co-cultured at 37°C for 5 days in RPMI1640 supplemented with 10% FBS
(all from Life Technologies), 100 units/ml penicillin and 100 μg/ml streptomycin
(Hyclone), 50ng/ml phorbol myristate acetate (PMA, P8139, Sigma-Aldrich), and 1μM
ionomycin (P9657, Sigma-Aldrich). After co-culture, the proliferation of the
CD4+ T cells was analyzed by assessing the intensity of the CFSE signal as
determined via flow cytometry (Calibur, BD Biosciences).
+ Open protocol
+ Expand
3

Culture and Expansion of Human Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mesenchymal stem cells (hMSCs, PT-2501, Lonza) were obtained from randomly selected healthy donors of both sexes with ages ranging from 19 to 38 years old and cultured in dedicated medium MSCBM (PT-3238) supplemented with 10% MCGS (PT-4106E), L-glutamine (PT-4107E), and gentamicin sulfate (GA-1000, PT-4504E, all Lonza), which was changed twice a week. Cells were maintained for up to 9 passages in 75 cm2 plastic bottom flasks and split once a week. For transgene induction experiments, cells were transferred to 24-well plates and seeded at a density of 1.5 × 104 cells/well. HEK293 cells served as controls and were cultivated in DMEM medium (31966 GlutaMAX, GIBCO) with 10% FBS (P40-37500HI, PAN™Biotech) and penicillin/streptomycin (P11-010, PAA). Cells were grown in 25 cm2 flasks, but for transfections assays were transferred to 24-well plates at a density of 70 × 103 cells/well. Both cell types were cultured in a humidified atmosphere at 37 °C and 5% CO2.
+ Open protocol
+ Expand
4

Isolation of Human MSC-Derived Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mesenchymal stem cells (MSC) were purchased from Lonza (Walkersville, MD, USA, #PT-2501) and cultured in a 175 cm2 flask with 25 mL mesenchymal stem cell media (Lonza, Walkersville, MD, USA, #PT-3001) in a humidified incubator at 37 °C with 5% CO2, according to manufacturer’s protocol. The cell propagation was limited to passage 10.
After reaching 80–90% confluency (about 1.5–2 million cells/flask), human MSCs were washed with 15mL PBS followed by adding 25 mL serum-free RPMI (Life Technologies) medium for another 24 h. MSC-derived EVs were collected from the culture medium by differential centrifugation at 2000 × g for 30 min to remove cell debris, and then, 100,000 × g for 1 h, collecting of the 100,000 × g pellet after. EVs were stored in PBS supplemented with 1% DMSO at −80 °C until EV DiD dye labeling. We used WX Ultra Centrifuge with Sorvall AH-629 rotor.
+ Open protocol
+ Expand
5

Comparative Analysis of hMSC Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two hMSC cell lines obtained from the bone marrow of healthy donors, provided by two different commercial suppliers – PT-2501 from a 21-year-old female and a 22-year-old female (Lonza Group Ltd, Basel, Switzerland), and C-12974 from a 64-year-old male (PromoCell GmbH, Heidelberg, Germany) – were used in this study. Because these cells are commercially available, no patient consent or approval from Ethics Committee was needed.
Cells were cultured at 37°C and 8% carbon dioxide with the media recommended by the manufacturer. The media were changed every other day and the cells were split enzymatically with Trypsin: 1× phosphate-buffered saline (Ref. 14190–185; Gibco Life Technologies) and Tryple Express (Ref. 12604–013; Gibco-Life Technologies) for PT-2501 cells, and the Trypsin kit (PromoCell GmbH) for C-12974 cells. Cultures were trypsinized when the cells were approximately 90% confluent.
+ Open protocol
+ Expand
6

3D Bone Mimetic Prostate Cancer Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MSCs (PT-2501) (Lonza) were maintained in MSCGM™ Bulletkit™ medium (Lonza, PT3001). Human prostate cancer cell line MDA-PCa-2b (PCa) is purchased from ATCC and kept in 80% BRFF-HPC-1 (AthenaES) and 20% FBS (ATCC). For 2D cultures, cells were seeded on tissue culture-treated Petri dishes. For 3D sequential culture, MSCs were seeded at a density of 5 × 104 cells per scaffold and cultured for 23 days to allow bone tissue formation. Further, prostate cancer cells PCa were seeded on newly formed bone tissue in the 3D bone mimetic scaffolds at a density of 5 × 104 cells and maintained in 1:1 MSCs and PCa medium (Supplementary Fig. 4).
+ Open protocol
+ Expand
7

Culturing Human and Porcine BM-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human BM-MSC commercial cell line was obtained from Lonza (Lonza, PT-2501). Porcine BM-MSCs were isolated from transgenic porcine embryos which constitutively expressed green fluorescent protein (GFP). Both human and porcine BM-MSCs were cultured in high-glucose DMEM (Dulbecco’s modified Eagle’s medium, Invitrogen) supplemented with 15% FBS (fetal bovine serum, Invitrogen) and 10 μg/ml gentamycin (Sigma Aldrich) in 5% CO2 at 37 °C. Culture medium was replaced every 2 days, and cells were passaged after reaching confluency. For further analysis, cells from passages 4–9 were used. Depending on the type of analysis, cells were collected and frozen (for further RNA isolation) or cultured on cover slides covered with a 1% gelatin solution and fixed with a 3% PFA (for protein immunolocalization).
+ Open protocol
+ Expand
8

hMSC Expansion and Comparative Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mesenchymal stem cells (hMSC) were obtained from Lonza (PT-2501) and were expanded in MSCGM for use in comparative flow cytometry and confocal analysis with MLPC.
+ Open protocol
+ Expand
9

Umbilical Cord Matrix Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two to three centimeters of term umbilical cord was purchased from LifeLine Stem Cells (New Haven, IN), and dissected in sterile Hank's Buffered Saline (Gibco, Canada) containing 1% gentamycin using aseptic technique. The vein and arteries were carefully removed. Pieces of Wharton's jelly (umbilical cord matrix) were then transferred to collagenase I and II (1 mg/ml, Gibco), diced into small pieces and incubated for up to 2 hours at 37°C on an orbital shaker. Ca2+ and Mg2+‐free phosphate‐buffered saline (PBS, Gibco) was then added to the viscous cell suspension prior to trituration and centrifugation at 2,000 rpm for 10 minutes at room temperature.
FTM HUCPVCs were isolated as per a published protocol 47 and were obtained from the CReATe Fertility Centre (Sunnybrook Research Institute Research Ethics Board Project Identification Number 454‐2011). An in vitro characterization and comparison between term and FTM HUCPVCs had been previously reported 47. Other cell types used included passage‐matched adult human BMSCs which were obtained commercially (PT‐2501, Lonza, Switzerland). The expression level of CD44 was revalidated for the three cell lines (Supporting Information Fig. S1).
+ Open protocol
+ Expand
10

Optimizing Genipin Crosslinking for hMSC Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MSCs (Lonza; PT-2501; hMSC) were expanded in low glucose-DMEM growth medium supplemented with 10% fetal bovine serum (FBS), and 1% penicillin/streptomycin (pen/strep). Cells between passage 5–7 were used for all the experiments.
To determine the optimal genipin concentration to crosslink cell-laden 3D CMA hydrogels, hMSCs were first cultured in 2D tissue culture plates and exposed to different concentrations of genipin (0 mM, 0.25 mM, 0.5 mM, 1mM, 5mM and 10 mM). Briefly, hMSCs were seeded in a 24-well plate at a density of 25,000 cells/cm2 and cultured for 24 h to allow for cell attachment. Following this, cells were incubated with different concentrations of genipin in 50 mM HEPES buffer for 1 h at 37 °C. Post genipin exposure, cells were washed three times and cultured in alpha-MEM culture medium supplemented with 10% FBS, 1% penicillin/streptomycin, and 10 mM β-glycerophosphate for an additional 24 h. At the end of culture, cells were washed with 1x PBS and stained with calcein AM and ethidium homodimer (Life Technologies) for 15 min at 37 °C and imaged under a fluorescence microscope (Zeiss) to assess the effect of genipin concentration on hMSC viability.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!